John Shen
Impact in
Papers in
-
- Prostate Cancer Treatment and Research 13
- Oncology 16
- Cancer Immunotherapy and Biomarkers 3
- Cancer Treatment and Pharmacology 2
- Co-authors
- Billy W. Loo (3 shared papers)Tokihiro Yamamoto (1 shared paper)Paul Keall (1 shared paper)U. W. Langner (1 shared paper)Daniel T. Chang (2 shared papers)Albert C. Koong (2 shared papers)Jeff Kim (1 shared paper)George A. Fisher (1 shared paper)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (4 papers)Journal of Clinical Oncology (3 papers)Scientific Reports (2 papers)JMIR mhealth and uhealth (2 papers)Annals of Oncology (2 papers)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
John Shen
33 papers receiving 977 citations
John Shen's Hit Papers
Peers
Comparison fields: 5 of 94
- Radiation 351
- Oncology 367
- Pulmonary and Respiratory Medicine 430
- Radiology, Nuclear Medicine and Imaging 294
- Cancer Research 131
Countries citing papers authored by John Shen
This map shows the geographic impact of John Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Shen more than expected).
Fields of papers citing papers by John Shen
This network shows the impact of papers produced by John Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Shen. The network helps show where John Shen may publish in the future.
Co-authors
The 25 scholars most cited alongside John Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 291 | |
| 2 | 2008 | 215 | |
| 3 | Phase 1/2 study of ARV-110, an androgen receptor (AR) PROTAC degrader, in metastatic castration-resistant prostate cancer (mCRPC). Hit paper breakdown → | 2022 | 125 |
| 4 | 2012 | 60 | |
| 5 | 2016 | 48 | |
| 6 | 2009 | 33 | |
| 7 | 2018 | 29 | |
| 8 | 2019 | 25 | |
| 9 | 2020 | 25 | |
| 10 | 2017 | 18 | |
| 11 | 2019 | 15 | |
| 12 | 2020 | 12 | |
| 13 | 2024 | 10 | |
| 14 | 2023 | 10 | |
| 15 | 2023 | 8 | |
| 16 | 2020 | 8 | |
| 17 | 2023 | 6 | |
| 18 | 2022 | 6 | |
| 19 | 2022 | 5 | |
| 20 | 2023 | 4 |
About John Shen
John Shen is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Surgery, having authored 36 papers that have together received 990 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (13 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Cancer, Lipids, and Metabolism (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Hormonal and reproductive studies (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), Advanced Radiotherapy Techniques (3 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Radiation (351 citations), Oncology (367 citations), Pulmonary and Respiratory Medicine (430 citations), Radiology, Nuclear Medicine and Imaging (294 citations) and Cancer Research (131 citations). John Shen has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Billy W. Loo, Tokihiro Yamamoto, Paul Keall, U. W. Langner, Daniel T. Chang, Albert C. Koong, Jeff Kim, George A. Fisher, Karyn A. Goodman and James M. Ford. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Scientific Reports, JMIR mhealth and uhealth and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.